With the analysis among 3,376 patents, we discovered top 467 key players by total patent application. Bristol Myers Squibb Co., Sanofi-Aventis Deutschland GmbH, Boehringer Ingelheim International GmbH are dominant in this area. They take 16.05% of the total patent filing.
New York, United States
Patent: 186
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 182
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 174
Basel-Stadt, Switzerland
Patent: 103
Hessen, Germany
Patent: 69
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 69
Hanmi Pharmaceutical Co., Ltd.
Fournier Laboratories Ireland Ltd.
North Carolina, United States
Patent: 52
Cambridgeshire, United Kingdom
Patent: 46
With the analysis among 54 patents, we discovered top 6 start-ups by total patent application. Anji Pharmaceuticals, Inc., Healx Ltd., Cellix Bio Pvt Ltd. are active in this area.
Anji Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 24
Cambridgeshire, United Kingdom
Patent: 10
Telangana, India
Patent: 9
Institut National de la Santé et de la Recherche Médicale
Shenzhen Hand Hitech Network Technology Co. Ltd.
Guangdong Sheng, China
Patent: 2
Vivera Pharmaceuticals, Inc.
California, United States
Patent: 2
With the analysis among related 968 patents applied in the last 5 years. We discover 389 most active companies in this area. The fast-growing Sanovel Ilaç Sanayi ve Ticaret AS, Eli Lilly & Co., Hanmi Pharmaceutical Co., Ltd. take 8.47% of patent filing during this period.
Sanovel Ilaç Sanayi ve Ticaret AS
Indiana, United States
Patent: 29
Hanmi Pharmaceutical Co., Ltd.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 18
The George Institute for Global Health
New South Wales, Australia
Patent: 17
Jiangsu Xiangrui Pharmaceutical Co., Ltd.
Glenmark Pharmaceuticals Ltd.
Maharashtra, India
Patent: 14
F. Hoffmann-La Roche Ltd.
Louisiana, United States
Patent: 12
With the analysis among related 968 patents in last 5 years, we discover 298 new entrants. DSM IP Assets BV, The George Institute for Global Health, Jiangsu Xiangrui Pharmaceutical Co., Ltd. are the most active new entrants in this area.
The George Institute for Global Health
New South Wales, Australia
Patent: 17
Jiangsu Xiangrui Pharmaceutical Co., Ltd.
F. Hoffmann-La Roche Ltd.
Louisiana, United States
Patent: 12
Cambridgeshire, United Kingdom
Patent: 10
Hanyi Biotechnology (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 6
Hainan Haili Pharmaceutical Co. Ltd.
Hainan Sheng, China
Patent: 5
Texas, United States
Patent: 5
Société des Produits Nestlé SA
Vaud, Switzerland
Patent: 5
With the analysis among 616 patents, we discovered top 139 universities and scientific research institutions by total patent application. University of Basel, Okayama University, Katholieke Universiteit Leuven are dominant in this area. They take 10.39% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 23
Okayama-ken, Japan
Patent: 21
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 15
President & Fellows of Harvard College
Massachusetts, United States
Patent: 14
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 11
Zhejiang Sheng, China
Patent: 10
University of Southern California
California, United States
Patent: 9
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 8
Tianjin Shi, China
Patent: 8
Guangdong Sheng, China
Patent: 7